Planned clinical trial of Staccato inhaled zaleplon for the treatment of patients with insomnia.

Trial Profile

Planned clinical trial of Staccato inhaled zaleplon for the treatment of patients with insomnia.

Suspended
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Zaleplon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 06 Nov 2012 Status changed from planning to suspended, as reported in an Alexza Pharmaceuticals media release.
    • 13 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top